Fewer than a third of parents plan to vaccinate their children for COVID-19 "right away" once the shots become available to 5- to 11-year-olds, according to a poll released Thursday.
Advisers to the Food and Drug Administration are debating Tuesday whether to recommend the COVID-19 vaccine from Pfizer-BioTech for emergency use in 5- to 11-year-olds, setting the stage for shots to become available to 28 million school-aged children by the start of November.
Advisers to the Food and Drug Administration are debating Tuesday whether to recommend the COVID-19 vaccine from Pfizer-BioTech for emergency use in 5- to 11-year-olds, setting the stage for shots to become available to 28 million school-aged children by the start of November.
A key advisory panel on Tuesday recommended the Pfizer-BioNTech COVID-19 shots for emergency use in children ages 5 to 11, setting the stage for shots to become available to 28 million children by early November and fueling debate over the risks and rewards of vaccinating an age group that's accounted for 0.01% of COVID-19 deaths in America.
A key advisory panel on Tuesday recommended the Pfizer-BioNTech COVID-19 shots for emergency use in children ages 5 to 11, setting the stage for shots to become available to 28 million children by early November and fueling debate over the risks and rewards of vaccinating an age group that's accounted for 0.01% of COVID-19 deaths in America.